Blood Purification

Acute Renal Failure/Multiorgan Failure: New Therapeutic Trends

Nutritional Aspects in Patients with Acute Renal Failure/ Multiorgan Failure

Alvestrand A.

Author affiliations

Department of Renal Medicine, Karolinska Institute, Stockholm, Sweden

Related Articles for ""

Blood Purif 1996;14:109–114

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Acute Renal Failure/Multiorgan Failure: New Therapeutic Trends

Published online: October 30, 2008
Issue release date: 1996

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU

Abstract

Nutrition support contributes to reducing morbidity and mortality in patients with the multiple-organ dysfunction syndrome (MODS). In cases when acute renal failure is a component of MODS, the goals of nutritional management should be to control general nutrient deficiencies and correct specific metabolic alterations caused by the loss of renal function or acute uraemia without worsening uraemic toxicity or disturbing electrolyte balance. In most cases energy requirements, which should ideally be estimated by indirect calorimetric measurements, amount to 30 kcal/kg/day and only seldom exceed 35 kcal/kg/day. Depending on the degree of protein catabolism, 1.0-1.5 g/kg/day of protein should be given. A balanced amino acid solution containing both essential and non-essential amino acids should be administered. Uraemia impairs protein synthesis and nitrogen administration should, therefore, not be started until the uraemic state is adequately controlled by dialysis or haemofiltration.

© 1996 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Acute Renal Failure/Multiorgan Failure: New Therapeutic Trends

Published online: October 30, 2008
Issue release date: 1996

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP